More deaths in the new study group for this product. More overall adverse reactions for the new product.

Here's the top-line comparison:

Healthcare encounter:

new: 80 (0.4)

existing: 120 (0.6)

Each group had roughly 20k participants, mostly white.

No actual control group, no independent third party study. Junk.